GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » EV-to-FCF

BNC Korea Co (XKRX:256840) EV-to-FCF : 27.71 (As of Jun. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is BNC Korea Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BNC Korea Co's Enterprise Value is ₩304,956 Mil. BNC Korea Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩11,004 Mil. Therefore, BNC Korea Co's EV-to-FCF for today is 27.71.

The historical rank and industry rank for BNC Korea Co's EV-to-FCF or its related term are showing as below:

XKRX:256840' s EV-to-FCF Range Over the Past 10 Years
Min: -229.87   Med: -16.11   Max: 103.53
Current: 26.02

During the past 8 years, the highest EV-to-FCF of BNC Korea Co was 103.53. The lowest was -229.87. And the median was -16.11.

XKRX:256840's EV-to-FCF is ranked worse than
54.58% of 535 companies
in the Drug Manufacturers industry
Industry Median: 22.83 vs XKRX:256840: 26.02

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), BNC Korea Co's stock price is ₩5710.00. BNC Korea Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩382.000. Therefore, BNC Korea Co's PE Ratio for today is 14.95.


BNC Korea Co EV-to-FCF Historical Data

The historical data trend for BNC Korea Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNC Korea Co EV-to-FCF Chart

BNC Korea Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -17.31 -8.23 -72.02 -8.43 20.80

BNC Korea Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.88 -12.86 -43.73 20.80 38.54

Competitive Comparison of BNC Korea Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, BNC Korea Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BNC Korea Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BNC Korea Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where BNC Korea Co's EV-to-FCF falls into.



BNC Korea Co EV-to-FCF Calculation

BNC Korea Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=304955.895/11004.231
=27.71

BNC Korea Co's current Enterprise Value is ₩304,956 Mil.
BNC Korea Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩11,004 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BNC Korea Co  (XKRX:256840) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

BNC Korea Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5710.00/382.000
=14.95

BNC Korea Co's share price for today is ₩5710.00.
BNC Korea Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩382.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


BNC Korea Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of BNC Korea Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BNC Korea Co (XKRX:256840) Business Description

Traded in Other Exchanges
N/A
Address
62 Seongseogongdan-ro 11-gil, Dalseo-gu, No 405, Structure 1, Daegu Techno Park Venture Factory, Daegu, KOR, 42713
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.

BNC Korea Co (XKRX:256840) Headlines

No Headlines